8.76
price down icon0.11%   -0.010
after-market 시간 외 거래: 8.77 0.010 +0.11%
loading
전일 마감가:
$8.77
열려 있는:
$8.75
하루 거래량:
1.99M
Relative Volume:
1.10
시가총액:
$548.56M
수익:
$91.06M
순이익/손실:
$-503.14M
주가수익비율:
-1.0441
EPS:
-8.39
순현금흐름:
$-424.74M
1주 성능:
-4.16%
1개월 성능:
-4.99%
6개월 성능:
+23.38%
1년 성능:
-15.61%
1일 변동 폭
Value
$8.75
$8.79
1주일 범위
Value
$8.74
$9.17
52주 변동 폭
Value
$4.62
$11.44

Sage Therapeutics Inc Stock (SAGE) Company Profile

Name
명칭
Sage Therapeutics Inc
Name
전화
617-299-8380
Name
주소
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
Name
직원
487
Name
트위터
@SageBiotech
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
SAGE's Discussions on Twitter

SAGE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SAGE
Sage Therapeutics Inc
8.76 547.94M 91.06M -503.14M -424.74M -8.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Sage Therapeutics Inc Stock (SAGE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-11 재개 BofA Securities Underperform
2024-11-21 업그레이드 RBC Capital Mkts Underperform → Sector Perform
2024-10-10 재개 Raymond James Mkt Perform
2024-10-04 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-07-30 다운그레이드 TD Cowen Buy → Hold
2024-07-25 다운그레이드 JP Morgan Overweight → Neutral
2024-05-29 개시 Citigroup Sell
2024-05-29 개시 Robert W. Baird Neutral
2024-04-17 다운그레이드 BofA Securities Neutral → Underperform
2023-12-12 개시 Deutsche Bank Hold
2023-08-08 다운그레이드 Canaccord Genuity Buy → Hold
2023-08-08 다운그레이드 Goldman Buy → Neutral
2023-08-08 다운그레이드 Needham Buy → Hold
2023-08-07 다운그레이드 BofA Securities Buy → Neutral
2023-08-07 다운그레이드 Oppenheimer Outperform → Perform
2023-08-07 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-08-07 다운그레이드 Stifel Buy → Hold
2023-08-07 다운그레이드 Wedbush Outperform → Neutral
2023-07-27 개시 Scotiabank Sector Outperform
2023-03-13 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2023-01-03 다운그레이드 Guggenheim Buy → Neutral
2022-11-01 개시 Loop Capital Hold
2022-03-31 개시 Berenberg Hold
2021-11-02 업그레이드 Guggenheim Neutral → Buy
2021-10-19 재개 Morgan Stanley Equal-Weight
2021-10-07 다운그레이드 Jefferies Buy → Hold
2021-09-23 개시 Needham Buy
2021-06-16 다운그레이드 Citigroup Buy → Neutral
2021-04-07 개시 Piper Sandler Overweight
2021-02-26 다운그레이드 Mizuho Buy → Neutral
2021-02-25 재확인 H.C. Wainwright Neutral
2021-02-02 재개 Raymond James Mkt Perform
2021-01-22 다운그레이드 BMO Capital Markets Outperform → Market Perform
2021-01-04 업그레이드 Guggenheim Neutral → Buy
2021-01-04 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2020-12-04 업그레이드 Mizuho Neutral → Buy
2020-12-01 다운그레이드 Raymond James Outperform → Mkt Perform
2020-11-16 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-11-06 재확인 H.C. Wainwright Neutral
2020-09-11 업그레이드 Wedbush Neutral → Outperform
2020-08-10 업그레이드 Raymond James Mkt Perform → Outperform
2020-05-08 다운그레이드 Wedbush Outperform → Neutral
2020-04-08 다운그레이드 Guggenheim Buy → Neutral
2020-03-18 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2020-03-06 개시 Citigroup Buy
2020-02-28 재확인 H.C. Wainwright Neutral
2020-02-06 개시 Mizuho Neutral
2019-12-06 재확인 RBC Capital Mkts Outperform
2019-12-05 재확인 Guggenheim Buy
2019-12-05 다운그레이드 SunTrust Buy → Hold
2019-10-30 개시 H.C. Wainwright Neutral
2019-05-23 개시 Wedbush Outperform
2019-04-25 개시 Jefferies Buy
2018-12-14 개시 Wolfe Research Outperform
2018-10-11 개시 Oppenheimer Outperform
모두보기

Sage Therapeutics Inc 주식(SAGE)의 최신 뉴스

pulisher
Jul 23, 2025

What drives Sage Therapeutics Inc. stock priceUnbelievable profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Sage Therapeutics Inc. stockFree Investment Community - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Sage Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Sage Therapeutics Inc. a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Layoff Tracker: GSK, Sail, BioNTech Cut Staff for Second Time This Year - BioSpace

Jul 22, 2025
pulisher
Jul 22, 2025

Sage Therapeutics (NASDAQ:SAGE) Sees Strong Trading VolumeHere's What Happened - MarketBeat

Jul 22, 2025
pulisher
Jul 20, 2025

Sage Therapeutics (NASDAQ:SAGE) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat

Jul 20, 2025
pulisher
Jul 18, 2025

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - 富途牛牛

Jul 18, 2025
pulisher
Jul 15, 2025

Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, - openPR.com

Jul 15, 2025
pulisher
Jul 15, 2025

Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Marinus Pharmac, Pfizer, UCB Biopharma, Rafa Laboratories, Sage Therapeutics - The Globe and Mail

Jul 15, 2025
pulisher
Jul 14, 2025

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc.SAGE - Business Wire

Jul 14, 2025
pulisher
Jul 13, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jul 13, 2025
pulisher
Jul 12, 2025

Sage Therapeutics (NASDAQ:SAGE) Downgraded to Hold Rating by Scotiabank - MarketBeat

Jul 12, 2025
pulisher
Jul 11, 2025

SAGE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Sage Therapeutics, Inc. is Fair to Shareholders - ACCESS Newswire

Jul 11, 2025
pulisher
Jul 11, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Connect - ACCESS Newswire

Jul 11, 2025
pulisher
Jul 10, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Average Rating of "Reduce" from Analysts - MarketBeat

Jul 10, 2025
pulisher
Jul 10, 2025

Sage Therapeutics (NASDAQ:SAGE) Rating Lowered to “Hold” at Scotiabank - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

Sage Therapeutics Announces Workforce Reductions Following Recent Acquisition Plans - geneonline.com

Jul 09, 2025
pulisher
Jul 09, 2025

Postpartum Depression Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | SAGE Therapeutics, Brii Biosciences Limited, Reunion Neuroscience, GH Research - Barchart.com

Jul 09, 2025
pulisher
Jul 08, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jul 08, 2025
pulisher
Jul 08, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, SAGE, OLO on Behalf of Shareholders - Morningstar

Jul 08, 2025
pulisher
Jul 08, 2025

Beyond The Numbers: 6 Analysts Discuss Sage Therapeutics Stock - Nasdaq

Jul 08, 2025
pulisher
Jul 08, 2025

SAGE: Scotiabank Downgrades Sage Therapeutics with Price Target Adjustment | SAGE Stock News - GuruFocus

Jul 08, 2025
pulisher
Jul 08, 2025

Scotiabank Downgrades SAGE Therapeutics to Sector Perform From Sector Outperform, Adjusts Price Target to $9.20 From $12 - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Wealth Enhancement Advisory Services LLC Takes $347,000 Position in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Jul 08, 2025
pulisher
Jul 08, 2025

Scotiabank Downgrades Sage Therapeutics (SAGE) - MSN

Jul 08, 2025
pulisher
Jul 07, 2025

Sage Therapeutics (NASDAQ:SAGE) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Jul 07, 2025
pulisher
Jul 06, 2025

Sage Therapeutics' Q1 Earnings Miss Mark, Revenue Rise Y/Y - MSN

Jul 06, 2025
pulisher
Jul 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jul 06, 2025
pulisher
Jul 06, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Consensus Rating of “Hold” from Analysts - Defense World

Jul 06, 2025
pulisher
Jul 04, 2025

Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 04, 2025
pulisher
Jul 03, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - Eastern Progress

Jul 03, 2025
pulisher
Jul 01, 2025

Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 01, 2025
pulisher
Jul 01, 2025

What Makes Sage Therapeutics (SAGE) a New Buy Stock - Yahoo Finance

Jul 01, 2025
pulisher
Jun 30, 2025

Sage to lay off most staff amid Supernus buyout - BioPharma Dive

Jun 30, 2025
pulisher
Jun 29, 2025

Levi & Korsinsky Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – SAGE - ACCESS Newswire

Jun 29, 2025
pulisher
Jun 27, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 27, 2025
pulisher
Jun 24, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jun 24, 2025
pulisher
Jun 23, 2025

Phathom Pharmaceuticals Strengthens Leadership: Sage Therapeutics Legal Head Joins GI-focused Biotech as CLO - Stock Titan

Jun 23, 2025
pulisher
Jun 20, 2025

SAGE: Baird Adjusts Price Target on Sage Therapeutics | SAGE Stock News - GuruFocus

Jun 20, 2025
pulisher
Jun 20, 2025

Canaccord Genuity Group Issues Positive Forecast for Sage Therapeutics (NASDAQ:SAGE) Stock Price - MarketBeat

Jun 20, 2025
pulisher
Jun 19, 2025

Needham & Company LLC Reiterates "Hold" Rating for Sage Therapeutics (NASDAQ:SAGE) - MarketBeat

Jun 19, 2025

Sage Therapeutics Inc (SAGE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
자본화:     |  볼륨(24시간):